Prot# C-1802: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Determine the Safety & Efficacy of Natalizumab, When Added to Avonex® (Interferon beta-1a), in Subjects w/ Relapsing-Remitting Multiple Sclerosis

    Project: Research project

    Project Details

    Description

    The NTRAIN program’s goal is to develop an integrated therapeutic biohybrid electronic system that the warfighter can use to control and adapt their own 24-hour temporal organization at central and peripheral levels in order to maximize readiness and performance, even when moving across time zones or experiencing shifts in mission requirements (e.g., changes from daytime to nighttime readiness). The success of this program will maximize warfighter performance by accelerating entrainment (by at least 50%) of the circadian and sleep/wake systems and mitigating disorganization of internalcircadian clocks.
    StatusFinished
    Effective start/end date3/21/024/2/07

    Funding

    • Air Force Research Laboratory (FA8650-21-2-7119)

    Fingerprint

    Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.